| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maxcyte, Inc. (MXCT) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. MXCT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 398.3K | $334.7K | - | |
| ? | 230.6K | $193.7K | - | |
| CEO | 175.0K | $147.0K | - | |
| CFO | 161.8K | $136.0K | - | |
| ? | 150.9K | $126.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | Sandoval David I. | General Counsel | Sell | 4,466 | $4.54 | $20,271.62 | -9.7% | -47.0% | -73.3% | |
| Dec 26, 2024 | Johnston John Joseph75 | Director | Sale+OE | 3,000 | $4.01 | $12,021.00 | -2.1% | -31.7% | -60.4% | |
| Dec 9, 2024 | Johnston John Joseph75 | Director | Sale+OE | 3,000 | $3.78 | $11,327.55 | -1.0% | -18.0% | -63.1% | |
| Nov 1, 2024 | Erck Stanley C86 | Director | Sale+OE | 47,689 | $3.72 | $177,403.08 | -15.1% | +21.8% | -59.2% | |
| Oct 28, 2024 | Johnston John Joseph75 | Director | Sale+OE | 3,000 | $3.72 | $11,166.00 | -2.1% | +25.2% | -57.1% | |
| Oct 2, 2024 | Erck Stanley C86 | Director | Sale+OE | 47,689 | $3.75 | $178,751.93 | -8.1% | +11.2% | -57.0% | |
| Sep 26, 2024 | Johnston John Joseph75 | Director | Sale+OE | 3,000 | $3.82 | $11,460.00 | -2.1% | +4.6% | -60.7% | |
| Sep 4, 2024 | Erck Stanley C86 | Director | Sale+OE | 47,689 | $4.02 | $191,655.19 | -8.1% | -8.2% | -65.1% | |
| Aug 26, 2024 | Johnston John Joseph75 | Director | Sale+OE | 3,000 | $4.28 | $12,840.00 | -2.1% | -16.6% | -67.9% | |
| Aug 2, 2024 | Ross Thomas M.82 | EVP, Global Sales | Sale+OE | 33,333 | $4.44 | $148,135.42 | -40.0% | -18.1% | -53.3% |